Sidley Updates
Top 10 FDA Areas We Are Watching For 2026
January 12, 2026
As 2026 begins, there is much to look forward to as companies and investors in the life sciences and medtech industries navigate a profoundly changing regulatory environment at FDA. With 2025 witnessing generational changes at FDA, we’re keeping an eye on opportunities and challenges for the year to come.
律师广告—Sidley Austin LLP 是一家全球性律师事务所。我们的地址及联系方式可在 www.sidley.com/en/locations/offices 查阅。
Sidley 提供本信息仅作为向客户及其他友好人士提供的服务，且仅供教育目的使用。本信息不应被解释或依赖为法律意见，亦不构成律师与客户关系。读者在未寻求专业顾问意见之前，不应依据本信息采取任何行动。Sidley 和 Sidley Austin 指 Sidley Austin LLP 及其关联合伙实体，详见 www.sidley.com/disclaimer。
© Sidley Austin LLP
联系我们
如果您对本次 Sidley 更新有任何疑问，请联系您平时合作的 Sidley 律师，或
Capabilities
Suggested News & Insights
Boston Life Sciences RoundtableTuesday, June 9, 2026Connecting Clusters of Excellence: Europe as Your Gateway to Global Success – Organized by Biovia, Health Campus Limburg DC, SidleyMonday, January 12, 2026FDA Release of Complete Response Letters Raises Confidentiality, Disclosure Questions But Offers Insights for DevelopmentJuly 11, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory